BlackRock’s Generation Bio GBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,070
Closed -$341K 5730
2025
Q4
$341K Sell
60,070
-46
-0.1% -$260 ﹤0.01% 4586
2025
Q3
$368K Sell
60,116
-56,042
-48% -$290K ﹤0.01% 4538
2025
Q2
$372K Sell
116,158
-224,360
-66% -$864K ﹤0.01% 4517
2025
Q1
$1.38M Sell
340,518
-5,389
-2% -$37.9K ﹤0.01% 4094
2024
Q4
$3.67M Buy
345,907
+4,307
+1% +$76.8K ﹤0.01% 3847
2024
Q3
$8.44M Buy
341,600
+12,175
+4% +$322K ﹤0.01% 3493
2024
Q2
$9.29M Buy
329,425
+24,540
+8% +$797K ﹤0.01% 3423
2024
Q1
$12.4M Sell
304,885
-11,957
-4% -$282K ﹤0.01% 3240
2023
Q4
$5.23M Sell
316,842
-18,532
-6% -$323K ﹤0.01% 3674
2023
Q3
$12.7M Sell
335,374
-18,322
-5% -$868K ﹤0.01% 3186
2023
Q2
$19.5M Buy
353,696
+9,060
+3% +$416K ﹤0.01% 3054
2023
Q1
$14.8M Sell
344,636
-26,171
-7% -$1.27M ﹤0.01% 3115
2022
Q4
$14.6M Buy
370,807
+9,202
+3% +$483K ﹤0.01% 3193
2022
Q3
$19.2M Buy
361,605
+11,409
+3% +$714K ﹤0.01% 3053
2022
Q2
$23M Buy
350,196
+33,315
+11% +$2.18M ﹤0.01% 3013
2022
Q1
$23.3M Buy
316,881
+115
+0% +$6.66K ﹤0.01% 3082
2021
Q4
$22.4M Buy
316,766
+4,252
+1% +$742K ﹤0.01% 3203
2021
Q3
$78.3M Buy
312,514
+27,500
+10% +$6.58M ﹤0.01% 2365
2021
Q2
$76.7M Sell
285,014
-6,332
-2% -$1.89M ﹤0.01% 2416
2021
Q1
$82.9M Buy
291,346
+157,657
+118% +$50.5M ﹤0.01% 2293
2020
Q4
$37.9M Buy
133,689
+66,565
+99% +$21.4M ﹤0.01% 2644
2020
Q3
$20.7M Buy
67,124
+65,174
+3,342% +$15.6M ﹤0.01% 2839
2020
Q2
$409K Buy
+1,950
New +$434K ﹤0.01% 4246

Other funds holding GBIO

BlackRock's GBIO Position: Q1 2026 in Review

BlackRock sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 60,070 shares — an estimated $341K sold.

BlackRock first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $82.9M in Q1 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

  • BlackRock reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
  • BlackRock sold 60,070 Generation Bio shares in Q1 2026, an estimated $341K.
  • BlackRock first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
  • BlackRock's Generation Bio position peaked at $82.9M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.